J Clin Med February 2023 PMID 36835917

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia.

Reed Mszar, Sarah Bart, Alexander Sakers, Daniel Soffer, Dean G Karalis

Download social card

Mentions

Peak: 12 in Feb 2023

across 2 sources since Feb 2023

Extended reach

132,011

potential audience

Total likes

Video views

Mentions per month

Feb 2023 – Jan 2025

Where it's discussed

X / Twitter17 posts
YouTube1 videos

AI synopsis

What people are saying

Most posts praise specific figures and concepts from the review, such as the mention of future lipid metabolism experts and the importance of public health policies, showing enthusiasm for scientific advances and societal applications. The tone ranges from supportive to thoughtful, indicating a good level of engagement and appreciation for the article's relevance.

AgreementModerate agreement

Most discussions acknowledge and support the importance of emerging therapies and the role of lifestyle and pharmacotherapy in managing HTG and ASCVD risk, indicating general agreement with the publication's findings.

InterestHigh interest

The discussions show a high level of interest in new scientific figures and the potential of emerging treatments, as well as the societal implications for public health.

EngagementModerate engagement

Posts include mentions of specific figures, the significance of lipid metabolism, and policy strategies, reflective of a moderately deep engagement with both scientific details and societal impacts.

ImpactModerate impact

The discussions emphasize potential improvements in clinical management and public health strategies, suggesting a belief in meaningful impact of the research.

Abstract in brief

Hypertriglyceridemia (HTG) is common in patients with cardiometabolic risk factors and increases the risk for atherosclerotic cardiovascular disease (ASCVD) if not properly managed.
Current guidelines recommend lifestyle changes and statins, alone or with other medications, for individuals with mild to moderate HTG; severe cases with risks like pancreatitis may also benefit from additional drugs such as fibrates or omega-3 fatty acids.
Emerging therapies targeting specific proteins like apoCIII and ANGPTL3 are promising for lowering triglycerides, but broader public health strategies are needed to improve access to treatments, healthy foods, and healthcare.]

Read the full abstract

All mentions

Advances in Hypertriglyceridemia Treatments and Cardiovascular Risk Reduction

This YouTube podcast discusses hypertriglyceridemia and therapies to reduce atherosclerotic cardiovascular disease risk. It covers current treatments like statins, fibrates, omega-3s, and niacin, as well as emerging…

Medical Matters with Shawn · Jan 18, 2025 17 views

Luis Davalos CARDIOLOGIA

@KKATODD · X

RT @dan_soffer: Sharing fantastic figure in recent review. Alex Sakers, future star in lipid/adipose metabolism and present master of BioRe…

Dec 28, 2023 · 4 shares · 689 followers View post →

Natsir Ramadhan

@natsiradhan · X

RT @dan_soffer: Sharing fantastic figure in recent review. Alex Sakers, future star in lipid/adipose metabolism and present master of BioRe…

Aug 30, 2023 · 4 shares · 557 followers View post →

Mike Kelly

@mikesbkelly · X

RT @dan_soffer: Sharing fantastic figure in recent review. Alex Sakers, future star in lipid/adipose metabolism and present master of BioRe…

Aug 30, 2023 · 4 shares · 386 followers View post →

Dan Soffer

@dan_soffer · X

Aug 30, 2023 · 25 likes · 4 shares · 1,302 followers View post →

Penn Cardiology

@PennCardiology · X

Due to the growing risks of #cardiometabolicdisease, public health & policy strategies are needed to

Mar 10, 2023 · 7 likes · 3 shares · 2,879 followers View post →

Dawn J

@dawnCJ100 · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 15, 2023 · 9 shares · 11,816 followers View post →

MDPI

@MDPIOpenAccess · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 15, 2023 · 9 shares · 44,121 followers View post →

Reed Mszar

@reed_mszar · X

Feb 15, 2023 · 4 likes · 680 followers View post →

Gustavo Lopes

@GustavoLopesO · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 13, 2023 · 9 shares · 154 followers View post →

Dr. Víctor M Larios

@dr_larios_cor · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 9, 2023 · 9 shares · 754 followers View post →

Melissa Lucas, PhD

@soy__meli · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 9, 2023 · 9 shares · 513 followers View post →

drjasonmccloskey

@drjmccloskey · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 9, 2023 · 9 shares · 81 followers View post →

Juanmarcosgg

@juanmarcosgg · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 9, 2023 · 9 shares · 510 followers View post →

Dr. Martha Gulati ♥️

@DrMarthaGulati · X

RT @reed_mszar: Our review on #triglyceride metabolism, HTG and

Feb 9, 2023 · 9 shares · 64,687 followers View post →

Reed Mszar

@reed_mszar · X

RT @dan_soffer: Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia https://t.…

Feb 9, 2023 · 1 share · 680 followers View post →

Reed Mszar

@reed_mszar · X

Our review on #triglyceride metabolism, HTG and

Feb 9, 2023 · 31 likes · 9 shares · 680 followers View post →

Dan Soffer

@dan_soffer · X

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia https://t.co/0NmQ3Qfi7L #mdpijcm via @JCM_MDPI

Feb 9, 2023 · 6 likes · 1 share · 1,302 followers View post →

Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

Advances in Hypertriglyceridemia Treatments and Cardiovascular Risk Reduction